丨2026年2月26日星期四丨 NO.1 先声药业2025年归母净利润预增80.1%至93.9% 2月25日，先声药业发布盈利预告，公司2025财政年度将录得收入约人民币77亿元至78亿元，同比增长约16.0%至17.6%；将录得归属于本公司权益股东的利润约人民币13亿元至14亿元，同比增长约80.1%至93.9%。 点评：公司的收入及利润增长与创新药收入、对外授权许可收入以及集团持有的投资...
Source Link丨2026年2月26日星期四丨 NO.1 先声药业2025年归母净利润预增80.1%至93.9% 2月25日，先声药业发布盈利预告，公司2025财政年度将录得收入约人民币77亿元至78亿元，同比增长约16.0%至17.6%；将录得归属于本公司权益股东的利润约人民币13亿元至14亿元，同比增长约80.1%至93.9%。 点评：公司的收入及利润增长与创新药收入、对外授权许可收入以及集团持有的投资...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.